21 CFR Part 314 Applications for FDA approval to market a new drug

Title:
21 CFR Part 314 Applications for FDA approval to market a new drug
Origin/Publisher:

US Federal Register

Document Type:
Code of Federal Regulations
Content:
This part sets forth procedures and requirements for the submission to, and the review by, the FDA of applications (including ANDA`s, supplements and postmarketing reports).

Go back